Steven M Swift

Title: Innovations of Steven M Swift

Introduction

Steven M Swift is an accomplished inventor based in Bethesda, MD, with a focus on biotechnological advancements. He holds two patents that contribute significantly to the field of microbiology and antibiotic alternatives. His work is particularly relevant in the context of increasing regulations against antibiotic use in animal feed.

Latest Patents

Swift's latest patents include "Thermophile peptidoglycan hydrolase fusion proteins and uses thereof" and "Characterization of four prophage endolysins specific for Clostridium perfringens." The first patent discusses chimeric recombinant lysins that comprise at least one thermophile endolysin catalytic domain and at least one cell wall binding domain. It also covers polynucleotides encoding these lysins and host cells expressing them. The second patent addresses the need for alternatives to antibiotics, particularly focusing on peptidoglycan hydrolases that target the cell wall of specific bacteria. This is crucial as Clostridium perfringens is a significant agent in food poisoning and necrotic enteritis.

Career Highlights

Throughout his career, Swift has worked with notable organizations, including the United States of America, as represented by the Secretary of Agriculture, and the University System of Maryland. His contributions to these institutions have been instrumental in advancing research in his field.

Collaborations

Swift has collaborated with esteemed colleagues such as David M Donovan and Jerel Waters, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Steven M Swift's innovative work in the field of microbiology and antibiotic alternatives showcases his commitment to addressing critical health issues. His patents reflect a significant advancement in the search for effective solutions to combat bacterial infections.